Posted on 10/26/20
Jazz Pharmaceuticals Acquires SpringWorks Therapeutics
Jazz Pharmaceuticals plc (Nasdaq: JAZZ) and SpringWorks Therapeutics, Inc. (Nasdaq: SWTX) today announced that Jazz Pharmaceuticals Ireland Limited and SpringWorks
Posted on 10/26/20
Vertex: Recent Clinical Setback Underscores The Need To Expand The Pipeline
SummaryThe market overreacted last week to the early-stage clinical program setback, the discontinuation of VX-814 due to toxicity problems.However, last week's reaction underscores the need to . . .
Posted on 10/26/20
How Much Is Moderna Really Worth?
The world's desperate need for vaccines and treatments to fight the COVID-19 pandemic has thrust a few companies into the limelight, including Moderna. The Massachusetts-based biotech, . . .
Posted on 10/26/20
Better Coronavirus Stock: Moderna or Novavax?
Moderna (NASDAQ:MRNA) and Novavax (NASDAQ:NVAX) have been taking turns at center stage with their coronavirus vaccine programs. Moderna grabbed investors' attention in March when it became . . .
Posted on 10/26/20
Why Is Everyone Talking About Moderna Stock?
Right now, nearly everyone in the healthcare investment world -- and perhaps in the general investment world -- is talking about Moderna (NASDAQ:MRNA). The biotech, which . . .
Posted on 10/23/20
Black Diamond Therapeutics: One To Watch In Precision Oncology Space
SummaryBlack Diamond is an innovative cancer drug-developer using genetic sequencing to identify families of allosteric mutations, and developing drug molecules to inhibit their proliferation.The company raised . . .
Posted on 10/23/20
Moderna Completes Enrollment in Its Late-Stage Coronavirus Vaccine Trial
Moderna (NASDAQ:MRNA) announced today that it has completed enrollment in the 30,000-participant study of mRNA-1273, the company's vaccine designed to protect against the novel coronavirus that . . .
Posted on 10/23/20
Foghorn Therapeutics Prices of IPO
CAMBRIDGE, Mass., Oct. 22, 2020 (GLOBE NEWSWIRE) -- Foghorn Therapeutics Inc. (Nasdaq: FHTX), a company pioneering the discovery and development of a new class of medicines . . .
Posted on 10/22/20
InVivo Therapeutics Prices $15.0 Million Public Offering
CAMBRIDGE, Mass.--(BUSINESS WIRE)--InVivo Therapeutics Holdings Corp. (NVIV) today announced the pricing of a public offering of 18,750,000 shares of its common stock, together with warrants to . . .
Posted on 10/22/20
AavantiBio Launches with $107 Million Series A Financing
A premier syndicate of life sciences investors including Perceptive Advisors, Bain Capital Life Sciences, and RA Capital Management together with Sarepta Therapeutics, Inc
Posted on 10/22/20
NeuroMetrix Reports Q3 2020 Financial Results
WOBURN, Mass., Oct. 22, 2020 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) today reported financial and business highlights for the quarter ended September 30, 2020. The . . .
Posted on 10/22/20
Cohere Health Closes Additional $10 Million in Funding
Cohere Health, an emerging high growth digital health company, announced today it closed an additional $10 million in funding led by Flare Capital Partners and Define . . .
Posted on 10/22/20
Better Buy: Moderna vs. Gilead Sciences
Two very different companies have been in the spotlight this year thanks to their coronavirus programs. Moderna (NASDAQ:MRNA) ranks as one of the leaders in the . . .
Posted on 10/21/20
Thermo Fisher Scientific Reports Third Quarter 2020 Results
Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today reported its financial results for the third quarter ended September 26, 2020.Third Quarter . . .
Posted on 10/21/20
Is Moderna Stock a Buy at This Price?
Moderna's (NASDAQ:MRNA) market cap has more than quadrupled since the beginning of this year on hopes that its coronavirus vaccine will protect people from COVID-19. In . . .
Posted on 10/21/20
Praxis Precision Medicines Closes of IPO
CAMBRIDGE, Mass., Oct. 20, 2020 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies . . .
Posted on 10/20/20
IQVIA Reports Third-Quarter 2020 Results
DANBURY, Conn. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV), a leading global provider of advanced analytics, technology solutions, and clinical research services to . . .
Posted on 10/29/20
Interview with Kevin Hrusovsky, Chairman & CEO, Quanterix
Spend a few minutes with Kevin Hrusovsky, President, CEO and Chairman of Quanterix, and you will quickly
Posted on 10/20/20
Harvard Business School and Harvard's Department of Stem Cell and Regenerative Biology Receive $25 Million Gift from Chris and Carrie Shumway
Harvard Business School (HBS) and Harvard's Department of Stem Cell and Regenerative Biology (HSCRB) have received a $25 million gift from Chris and Carrie Shumway (MBA . . .
Posted on 10/20/20
Floating Hospital for Children Renamed Tufts Children’s Hospital
New name more memorable, strengthens ties to Tufts Medical CenterChanging its name from Floating Hospital for Children to Tufts Children’s Hospital has given the125 year-old hospital . . .
Posted on 10/20/20
Biogen: Neurology Leader Pivots To Gene Therapy
SummaryBiogen has embraced Ionis antisense technology for neurology targets.A new Gene Therapy Accelerator Unit was formed last year and has facilitated the creation of new business . . .
Posted on 10/19/20
Fenway Health Activated As COVID-19 Antibody Study Trial Site
Boston-based Fenway Health has been activated as a late-stage clinical trial site for the CoVPN 3502 monoclonal antibody study to prevent COVID-19 disease among household members . . .
Posted on 10/19/20
CVS Health to Hire 15,000 Across the U.S. in Fourth Quarter
CVS Health (NYSE: CVS) today announced that it is recruiting qualified candidates to fill 15,000 jobs. These new and existing positions will help the company continue . . .
Posted on 10/19/20
Mevion Partners with Hermes Advanced Therapy Systems to Expand Reach in Asia
LITTLETON, Mass.--(BUSINESS WIRE)--Mevion Medical Systems is pleased to announce it has entered a partnership agreement with Hermes Advanced Therapy Systems Corp. (HATS) for the distribution of . . .
Posted on 10/19/20
Why I Think Bristol Myers Squibb Is Too Cheap to Miss
For investors in pharmaceutical companies, few things are more concerning than a loss of market share, particularly if it's because of the patent expiration of a . . .
Boston
